Literature DB >> 16552804

Alanyl-glutamine dipeptide inhibits hepatic ischemia-reperfusion injury in rats.

Chang-Jun Jia1, Chao-Liu Dai, Xu Zhang, Kai Cui, Feng Xu, Yong-Qing Xu.   

Abstract

AIM: To investigate the protective effect and mechanism of alanyl-glutamine dipeptide (Ala-Gln) against hepatic ischemia-reperfusion injury in rats.
METHODS: Rats were divided into group C as normal control Group (n=16) and group G as alanyl-glutamine pretreatment (n=16). Rats were intravenously infused with 0.9% saline solution in group C and Ala-Gln -enriched (2% glutamine) 0.9% saline solution in group G via central venous catheter for three days. Then all rats underwent hepatic warm ischemia for 30 min followed by different periods of reperfusion. Changes in biochemical parameters,the content of glutathione (GSH) and the activity of superoxide dismutase (SOD) in liver tissue, Bcl-2 and Bax protein expression and morphological changes of liver tissue were compared between both groups.
RESULTS: One hour after reperfusion, the levels of liver enzymes in group G were significantly lower than those in group C (P<0.05).Twenty-four hours after reperfusion, the levels of liver enzymes in both groups were markedly recovered and the levels of liver enzyme in group G were also significantly lower than those in group C (P<0.01). One and 24 h after reperfusion, GSH content in group G was significantly higher than that in group C (P<0.05). There was no statistical difference in activities of SOD between the two groups. One and 24 h after reperfusion, the positive expression rate of Bcl-2 protein was higher in group G than in group C (P<0.05) and the positive expression rate of Bax protein was lower in group G than in group C (P<0.05). Histological and ultrastructural changes of liver tissue were inhibited in group C compared to group G.
CONCLUSION: Our results suggest that Ala-Gln pretreatment provides the rat liver with significant tolerance to warm ischemia-reperfusion injury,which may be mediated partially by enhancing GSH content and regulating the expression of Bcl-2 and Bax proteins in the liver tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552804      PMCID: PMC4124313          DOI: 10.3748/wjg.v12.i9.1373

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Heat shock protein 72 normothermic ischemia, and the impact of congested portal blood reperfusion on rat liver.

Authors:  C L Dai; Z L Xia; M Kume; Y Yamamoto; K Yamagami; N Ozaki; Y Yamaoka
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Glutathione and ultrastructural changes in inflow occlusion of rat liver.

Authors:  T Armeni; R Ghiselli; G Balercia; L Goffi; W Jassem; V Saba; G Principato
Journal:  J Surg Res       Date:  2000-02       Impact factor: 2.192

3.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

Authors:  L M Colletti; D G Remick; G D Burtch; S L Kunkel; R M Strieter; D A Campbell
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  Glutamine improves impaired cellular exudation and polymorphonuclear neutrophil phagocytosis induced by total parenteral nutrition after glycogen-induced murine peritonitis.

Authors:  Shigeo Ikeda; Kenneth A Kudsk; Tho Le; Ben L Zarzaur; Cheryl D Johnson
Journal:  Shock       Date:  2003-01       Impact factor: 3.454

Review 5.  Glutamine: recent developments in research on the clinical significance of glutamine.

Authors:  Gerdien C Melis; Nathalie ter Wengel; Petra G Boelens; Paul A M van Leeuwen
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2004-01       Impact factor: 4.294

6.  Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of ischemic postconditioning.

Authors:  Kai Sun; Zhi-Su Liu; Quan Sun
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

7.  Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin.

Authors:  P A van Leeuwen; R W Hong; J D Rounds; M L Rodrick; D Wilmore
Journal:  Surgery       Date:  1991-08       Impact factor: 3.982

Review 8.  Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liver.

Authors:  Shigeki Arii; Kennichi Teramoto; Toru Kawamura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

9.  Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury.

Authors:  Paul E Wischmeyer; David Jayakar; Ursula Williams; Kristen D Singleton; Jacob Riehm; Emile A Bacha; Valluvan Jeevanandam; Uwe Christians; Natalie Serkova
Journal:  JPEN J Parenter Enteral Nutr       Date:  2003 Nov-Dec       Impact factor: 4.016

10.  Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation.

Authors:  Rolf J Schauer; Sinan Kalmuk; Alexander L Gerbes; Rosemarie Leiderer; Herbert Meissner; Friedrich W Schildberg; Konrad Messmer; Manfred Bilzer
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

View more
  4 in total

1.  Ameliorative effect of supplementation with L-glutamine on oxidative stress, DNA damage, cell viability and hepatotoxicity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat hepatocyte cultures.

Authors:  Hasan Turkez; Fatime Geyikoglu; Mokhtar I Yousef; Kubra Celik; Tulay O Bakir
Journal:  Cytotechnology       Date:  2012-03-28       Impact factor: 2.058

2.  Alanyl-Glutamine Protects against Lipopolysaccharide-Induced Liver Injury in Mice via Alleviating Oxidative Stress, Inhibiting Inflammation, and Regulating Autophagy.

Authors:  Jiaji Hu; Hanglu Ying; Yigang Zheng; Huabin Ma; Long Li; Yufen Zhao
Journal:  Antioxidants (Basel)       Date:  2022-05-27

3.  Protection of rat liver against hepatic ischemia-reperfusion injury by a novel selenocysteine-containing 7-mer peptide.

Authors:  Qianqian Jiang; Yu Pan; Yupeng Cheng; Huiling Li; Hui Li
Journal:  Mol Med Rep       Date:  2016-07-01       Impact factor: 2.952

4.  Glutamine ameliorates lipopolysaccharide-induced cardiac dysfunction by regulating the toll-like receptor 4/mitogen-activated protein kinase/nuclear factor-kB signaling pathway.

Authors:  Wen-Bin Zhang; Hai-Yue Zhang; Qian Zhang; Fang-Zhou Jiao; Hong Zhang; Lu-Wen Wang; Zuo-Jiong Gong
Journal:  Exp Ther Med       Date:  2017-10-17       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.